AN ACT ESTABLISHING AN ADVISORY COUNCIL ON CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY AND OTHER GENE THERAPIES.

Summary

The bill establishes an advisory council that will advise the Department of Public Health and other agencies on the availability, safety, cost, training, and equity of CAR‑T and other gene‑based cancer treatments. The council includes state officials, medical experts, patient representatives, and industry stakeholders, and it must meet at least quarterly and report annually to the legislature. The measure aims to improve access to cutting‑edge therapies while ensuring patient safety and fair coverage.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share